Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) on Friday, soared 4.44% from the previous trading day, before settling in for the closing price of $5.40. Within the past 52 weeks, AMLX’s price has moved between $1.58 and $19.95.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 2300.59% over the last five years. The company achieved an average annual earnings per share of -623.81%. With a float of $41.21 million, this company’s outstanding shares have now reached $67.71 million.
The firm has a total of 384 workers. Let’s measure their productivity. In terms of profitability, gross margin is 53.5%, operating margin of -51.85%, and the pretax margin is -54.35%.
Amylyx Pharmaceuticals Inc (AMLX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Amylyx Pharmaceuticals Inc is 39.47%, while institutional ownership is 70.93%. The most recent insider transaction that took place on Sep 30 ’24, was worth 59,429. In this transaction Co-Chief Executive Officer of this company sold 18,589 shares at a rate of $3.20, taking the stock ownership to the 3,120,569 shares. Before that another transaction happened on Sep 30 ’24, when Company’s Co-Chief Executive Officer sold 18,589 for $3.20, making the entire transaction worth $59,414. This insider now owns 3,220,569 shares in total.
Amylyx Pharmaceuticals Inc (AMLX) Recent Fiscal highlights
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported 0.3 earnings per share (EPS) for the period falling under the consensus outlook (set at 0.43) by -0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -623.81% per share during the next fiscal year.
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) Trading Performance Indicators
Amylyx Pharmaceuticals Inc (AMLX) is currently performing well based on its current performance indicators. A quick ratio of 4.66 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.45, a number that is poised to hit -0.70 in the next quarter and is forecasted to reach -1.73 in one year’s time.
Technical Analysis of Amylyx Pharmaceuticals Inc (AMLX)
Analysing the last 5-days average volume posted by the [Amylyx Pharmaceuticals Inc, AMLX], we can find that recorded value of 1.43 million was lower than the volume posted last year of 2.04 million. As of the previous 9 days, the stock’s Stochastic %D was 81.95%. Additionally, its Average True Range was 0.43.
During the past 100 days, Amylyx Pharmaceuticals Inc’s (AMLX) raw stochastic average was set at 96.21%, which indicates a significant increase from 93.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 101.29% in the past 14 days, which was higher than the 80.57% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.36, while its 200-day Moving Average is $4.86. Now, the first resistance to watch is $5.82. This is followed by the second major resistance level at $6.01. The third major resistance level sits at $6.21. If the price goes on to break the first support level at $5.43, it is likely to go to the next support level at $5.23. Now, if the price goes above the second support level, the third support stands at $5.05.
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) Key Stats
Market capitalization of the company is 401.06 million based on 68,082K outstanding shares. Right now, sales total 380,790 K and income totals 49,270 K. The company made 88,640 K in profit during its latest quarter, and -118,790 K in sales during its previous quarter.
